During this almost year-long severe global economic downturn, much talk has centered on government efforts around the world to create stimulus packages to jump-start financial activity. Indeed, a number of nations are already pumping or thinking of pumping money into the business sector to create jobs, support new companies, or bolster faltering firms. Recently there have been suggestions that governments should earmark some stimulus funds for support of venture capital companies who are placing their bets on new biotechnology firms. What do you think?

Poll Question:
Should national governments partner with venture capital firms to raise funds for, invest in, and help support the development of new biotechnology firms?



No Opinion

Previous articleTop-10 Session Picks for the 2009 BIO International Convention
Next articleiZumi Bio and Japanese Stem Cell Research Center to Collaborate